Evidence map›Paper›PMID 42681098›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2026

Synthesis of Hydroxamate-Type Siderophores and Their Conjugates with PNA for Evaluation of Iron Binding and Bacterial Uptake.

Monika Wojciechowska, Uladzislava Tsylents, Joanna Trylska

Abstract read
PubMed Publisher
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Monika WojciechowskaUniversity of Warsaw, Centre of New Technologies, Warsaw, Poland.
Uladzislava TsylentsUniversity of Warsaw, Centre of New Technologies, Warsaw, Poland.
Joanna TrylskaUniversity of Warsaw, Centre of New Technologies, Warsaw, Poland. joanna@cent.uw.edu.pl.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Applications of peptide nucleic acids (PNAs) against bacteria are limited by their poor cellular uptake. We used a Trojan horse strategy for PNA delivery into gram-negative bacteria via TonB-dependent transport systems. To apply this strategy, iron-chelators (siderophores) covalently linked to PNA oligomers are used as PNA carriers. These siderophores bind ferric iron and are recognized and taken up by cells together with the attached PNA. Here, we describe the synthesis of PNA conjugates with hydroxamate-type siderophores that can be synthesized based on peptide chemistry. The conjugates are prepared through copper(I)-catalyzed azide-alkyne cycloaddition (CuAAC), enabled by the incorporation of azide and alkyne functionalities into the siderophore and PNA scaffolds, respectively. Synthetic procedures, including solid-phase synthesis of PNA oligomers and siderophores, are provided. We also outline protocols for evaluating the iron-binding capacity of the siderophores, as well as methods for confirming their ability to form octahedral iron complexes with defined Δ/Λ chirality. This is to ensure that upon conjugation with PNA these ferric siderophore-PNA complexes are recognized by the TonB-dependent receptors. This strategy provides a foundation for developing targeted PNA-based antimicrobial agents using native bacterial uptake pathways.

Indexed as

Hydroxamic AcidsIronPeptide Nucleic AcidsSiderophoresBiological TransportSolid-Phase Synthesis TechniquesHydroxamic AcidsIronPeptide Nucleic AcidsSiderophoresAntibacterial agentsBacterial TonB-dependent transport systemClick chemistryHydroxamate siderophoresIron chelatorsOrnithinesPeptide nucleic acid (PNA)PNA deliverySiderophore-PNA conjugates

Identifiers

PMID42681098

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.